Publicaties/publications Rift Valley Fever Virus

Wichgers Schreur, P. J., Kortekaas, J. 2016. Single-Molecule FISH Reveals Non-selective Packaging of Rift Valley Fever Virus Genome Segments. PLoS Pathog. 12: e1005800. Doi: 10.1371/journal.ppat.1005800. Castellum.

Birgit Makoschey, Emma van Kilsdonk, Willem R. Hubers, Mieke P. Vrijenhoek, Marianne Smit, Paul J. Wichgers Schreur, Jeroen Kortekaas, Véronique Moulin; 2016. Rift Valley Fever Vaccine Virus Clone 13 Is Able to Cross the Ovine Placental Barrier Associated with Foetal Infections, Malformations, and Stillbirths; Plos Negalected Tropical Diseases, March 31, 2016

Paul J Wichgers Schreur, Lucien Van Keulen, Jet Kant, Nadia Oreshkova, Rob Moormann and Jeroen Kortekaas. 2016. Co-housing of Rift Valley fever virus infected lambs with immunocompetent or immunosuppressed lambs does not result in virus transmission.  Front. Microbiol. 7: 287. Doi:10.3389/fmicb.2016.00287. WOT-01-003-064.

Oreshkova, N., Wichgers Schreur, P. J., Spel, L., Vloet, R. P., Moormann, R. J., Boes, M., Kortekaas, J. 2015. Nonspreading Rift Valley Fever Virus Infection of Human Dendritic Cells Results in Downregulation of CD83 and Full Maturation of Bystander Cells. PLoS ONE 10 (11) 0142670. B-12-004.02-003.

FAO Report Ad hoc workshop on the current state of Rift Valley Fever vaccine and diagnostics development, Rome, March 2014 The Last Hurdles towards Rift Valley Fever control

Paul J. Wichgers Schreur, Jet Kant, Lucien van Keulen, Rob J.M. Moormann, Jeroen Kortekaas. 2015. Four-segmented Rift Valley fever virus induces sterile immunity in sheep after a single vaccination. Vaccine 33: 1459-1464. (Castellum)

Kortekaas, J. 2014. One Health approach to Rift Valley fever vaccine development. Antiviral Res. 106: 24-32.

Kortekaas, J., Oreshkova, N., van Keulen, L., Kant, J., Bosch, B. J., Bouloy, M., Moulin, V., Goovaerts, D., Moormann, R. J. 2014. Comparative efficacy of two next-generation Rift Valley fever vaccines. Vaccine 32: 4901-4908.

Wichgers Schreur, P. J., Oreshkova, N., Moormann, R. J., Kortekaas, J. 2014. Creation of Rift Valley fever viruses with four-segmented genomes reveals flexibility in bunyavirus genome packaging. J. Virol. 88: 10883-10893.

Oreshkova, N., Cornelissen, L. A., de Haan, C. A., Moormann, R. J., Kortekaas, J. 2014. Evaluation of nonspreading Rift Valley fever virus as a vaccine vector using influenza virus hemagglutinin as a model antigen. Vaccine 32: 5323-5329.

Nadia Oreshkova, Lucien van Keulen, Jet Kant, Rob J. M. Moormann, Jeroen Kortekaas. 2013.  A Single Vaccination with an Improved Nonspreading Rift Valley Fever Virus Vaccine Provides Sterile Immunity in Lambs. PLoS ONE 8(10): e77461. doi10.1371/journal.pone.0077461.

Fischer, E.A.J., Boender, G-J., Nodelijk, G., de Koeijer, A.A., van Roermund, H.J.W. 2013. The transmission potential of Rift Valley fever virus among livestock in the Netherlands: a modelling study. Vet. Res. 44: 58. BO-08-010-022

Antonis, A F G, Kortekaas, J, Kant, J, Vloet, R P M, Vogel-Brink, A, Stockhofe, N, Moormann, R J M. 2013. Vertical Transmission of Rift Valley Fever Virus Without Detectable Maternal Viremia. Vector Borne Zoonotic Dis. 13: 601-606. BO-10-006-084

Kortekaas, J., Kant, J., Vloet, R., Cetre-Sossah, C., Marianneau, P., Lacote, S., Banyard, A.C., Jeffries, C., Eiden, M., Groschup, M., Jackel, S., Hevia, E., Brun, A. 2013. European ring trial to evaluate  ELISAs for the diagnosis of infection with Rift Valley fever virus. J. Virol. Meth. 187: 177-181. EPIZONE network of Excellence: FOOD-CT-2006-016236.

J. Kortekaas, A.F.G. Antonis, J. Kant, R.P.M. Vloet, A. Vogel, Nadia Oreshkova, S.M. de Boer, B.J. Bosch, R.J.M. Moormann. 2012. Efficacy of three candidate Rift Valley fever vaccines in sheep. Vaccine 30: 3423-3429.

F.J. van der Wal, R.P. Achterberg, S.M. de Boer, H. Boshra, A. Brun, C.B.M. Maassen and J. Kortekaas. 2012. Bead-based suspension array for simultaneous detection of antibodies against the Rift Valley fever virus nucleocapsid and Gn glycoprotein. J. Virol. Meth. 183: 99-105.

S.M. de Boer, J. Kortekaas, C.A.M. de Haan, P.J.M. Rottier, R.J.M. Moormann and B.J. Bosch; 2012. Heparan sulfate facilitates Rift Valley fever virus entry into the celll; Journal of Virology 86 (24) 13767-13771

S.M. de Boer, J. Kortekaas, L. Spel, P.J.M. Rottier, R.J.M. Moormann and B.J. Bosch; 2012. Acid-activated structural reorganization of the Rift Valley fever virus Gc fusion protein; Journal of Virology 86 (24) 13642-13652

Kortekaas, J.A.; Oreshkova, N.D.; Cobos-Jeménez, V.; Vloet, R.P.M.; Potgieter, C.; Moormann, R.J.M. (2011) Creation of a Nonspreading Rift Valley Fever Virus Journal of Virology 85 (23). - p. 12622 - 12630.

Boer, S.M. de; Kortekaas, J.A.; Antonis, A.F.G.; Kant, J.; Oploo, J.L. van; Rottier, P.J.M. (2010) Rift Valley fever virus subunit vaccines confer complete protection against a lethal virus challenge Vaccine 28 (11). - p. 2330 - 2339.

Kortekaas, J.A.; Ergonul, O.; Moormann, R.J.M. (2010) Interventions Against West Nile Virus, Rift Valley Fever Virus, and Crimean-Congo Hemorrhagic Fever Virus: Where Are We? Vector-Borne and Zoonotic Diseases 10 (7). - p. 709 - 718.

Kortekaas, J.A.; Dekker, A.; Boer, S.M. de; Weerdmeester, K.; Vloet, R.P.M.; Wit, A.A.C. de; Peeters, B.P.H.; Moormann, R.J.M. (2010) Intramuscular inoculation of calves with an experimental Newcastle disease virus-based vector vaccine elicits neutralizing antibodies against Rift Valley fever virus Vaccine 28 (11). - p. 2271 - 2276.

Kortekaas, J.A.; Boer, S.M. de; Kant, J.; Vloet, R.P.M.; Antonis, A.F.G.; Moormann, R.J.M. (2010) Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector Vaccine 28 (27). - p. 4394 - 4401